Fungemia overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Fungemia''' is the presence of [[fungus|fungi]] or [[yeast]]s in the [[blood]]. It is most commonly seen in [[immunosuppressed]] or [[immunocompromised]][[patient]]s with severe [[neutropenia]], [[oncology]] patients, or in patients with intravenous [[catheter]]s. Recently, it has been suggested the otherwise immunocompetent patients taking [[infliximab]] may be at a higher risk for fungemia. | '''Fungemia''' is the presence of [[fungus|fungi]] or [[yeast]]s in the [[blood]]. It is most commonly seen in [[immunosuppressed]] or [[immunocompromised]] [[patient]]s with severe [[neutropenia]], [[oncology]] patients, or in patients with intravenous [[catheter]]s. Recently, it has been suggested the otherwise immunocompetent patients taking [[infliximab]] may be at a higher risk for fungemia. | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:13, 7 December 2012
|
Fungemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fungemia overview On the Web |
|
American Roentgen Ray Society Images of Fungemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fungemia is the presence of fungi or yeasts in the blood. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. Recently, it has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.